FORM 8-K CURRENT REPORT

Company

Actinium Pharmaceuticals, Inc.

Filed

December 17, 2012

Period of Report

August 30, 2012

Accession Number

0001078782-12-003207

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →